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Abstract
Background: In responding to the health challenges of climate change, those responsible for health policies and
resource allocations need to know the resource consequences of their decisions. This article examines the
availability and strength of economic evidence for policy makers to draw on in making health policy decisions.
Methods: Relevant literature was obtained using a Medline and INTERNET search of key terms and institutions
working in health and climate change. Eighteen available economic studies are presented under three categories
of economic evidence: health damage cost, health adaptation cost and health economic evaluation.
Results: In economic studies valuing the predicted increased mortality from climate change, the health damages
represent an important fraction of overall economic losses. Similarly, when considering broader health protection
measures beyond the health sector (e.g. agriculture, water supply) health considerations are central. Global
adaptation cost studies carried out so far indicate health sector costs of roughly US$2-5 billion annually (mid-
estimates). However, these costs are expected to be an underestimate of the true costs, due to omitted health
impacts, omitted economic impacts, and the costs of health actions in other sectors. No published studies
compare the costs and benefits of specific health interventions to protect health from climate change.
Conclusions: More economic studies are needed examining the costs and benefits of adaptation measures to
inform policy making. There is an urgent need for climate change-specific health economic guidelines to ensure
robust methods are used, giving comparable results. Broader advocacy and focused training of decision makers is
needed to increase the uptake of economic evidence in decision making. Until further climate change-specific
economic studies have been conducted, decision makers should selectively draw on published studies of the costs
and benefits of environmental health interventions.
Background
In responding to the health challenges of climate
change, those responsible for international and national
health policies and budget allocations need to know the
resource consequences of their decisions. These include
the size of costs, benefits and financing of policy imple-
mentation, the distribution of gains, as well as unin-
tended or negative consequences of health policies.
Economic research attempts to answer these questions.
However, what economic evidence can policy makers
actually draw on in making their decisions regarding cli-
mate change? And how accessible is that evidence?
The global evidence base on the economics of climate
change is extremely weak, especially in the health
sphere. Little is known still on the precise health
impacts of climate change at a sub-national level, their
economic costs, and the costs and benefits of measures
to protect health from climate change. Also, given that
climate change is a long-term event, there is currently
very limited information on how economic development
generally, and health sector development in particular,
will protect the health of populations from future cli-
mate change, especially in poor but rapidly developing
nations. Therefore, having a better understanding of the
costs and benefits of health policies and programmes is
one concrete way to assist policy makers in making bet-
ter decisions. The aim of this article is to examine the
availability and strength of economic evidence for policy
makers to draw on in making health decisions, and to
provide recommendations for future evidence generation
and dissemination.
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Relevant literature was obtained using a Medline and
INTERNET search of key terms and institutions work-
ing in health and climate change. Studies were screened
for whether they presented quantitative health economic
data on climate change, using title and abstract (where
available). From 37 publications initially screened using
title and/or abstract, 18 were found to present original
data once the full publication was obtained. Other publi-
cations presenting compiled evidence and reviewing eco-
nomic issues were also collected, and where relevant are
reported. For simplicity, economic studies can be
broadly divided into three categories:
1. Health damage cost studies estimate the societal
costs or benefits of the health impacts of different cli-
mate change scenarios. 12 studies were identified and
are presented below. Scenarios typically compare busi-
ness-as-usual with global average temperature rise under
different greenhouse gas emissions mitigation measures,
and the associated health impacts [1,2]. This approach
values the health outcomes in monetary units. The pri-
mary purpose of these studies is to provide advocacy
material to raise attention to the negative consequences
of climate change. Data from these studies also feed into
other types of economic assessment (see 3. below).
2. Health adaptation cost studies estimate the costs of
alternative measures to reduce, or avert altogether, the
health impacts of climate change. 3 global studies and 2
country studies were identified and are presented below.
Measures can be a combination of preventive and curative
interventions taken by the health sector as well as health-
affecting measures in other sectors. The primary purpose of
these studies is to enable realistic budgeting for the inter-
ventions required for adaptation, now and in the future.
3. Health economic evaluation studies essentially com-
pare the costs with the benefits of health adaptation
measures, estimating a return on spending in the form
of a cost-effectiveness ratio (such as cost per death
averted) or a cost-benefit ratio (monetary return per
currency unit spent) [3]. When efficiency measures are
provided for a range of alternative adaptation measures,
policy makers are enabled to select measures using effi-
ciency and other criteria, based on policy goals. 1 study
was identified and is presented below.
The economic evidence base is reviewed under these
three categories, focusing on the eighteen available stu-




Newspaper headlines that announce the number of “bil-
lion dollars lost per year due to climate change” can
lend political and public support to new adaptation and
mitigation policies. However, the general public, and
even policy makers, often do not understand what is
behind the numbers, such as which impacts are included
and excluded, and the robustness of the data sources
and valuation methods.
First, not all health damages can be easily monetized.
Many health and environmental impacts are intangible
or difficult to measure, such as the loss of quality of life
or the loss of life itself. Second, some are indirect such
as impact on household income and therefore more dif-
ficult to attribute precisely to the health impact. Due to
these challenges, most studies value only the most direct
and quantifiable economic impacts, leading to a sys-
tematic under-valuation of the health effects of climate
change. Table 1 classifies different damage costs accord-
ing to their tangibility and directness, based on author’s
assessment.
Health damage cost estimates are commonly made as
part of broader studies on the overall economic costs of
climate change. The majority of economic damage cost
studies are global and regional in scope. Studies from
the 1990s show total damage costs of climate change
equivalent to 1% to 3% of GDP, for a commonly mod-
elled (in those days) average global temperature rise of
2.5°C. The global economic value of loss of life due to
climate change varies between around US$6 billion and
US$88 billion, in 1990 US$ [4-9]. The contribution of
the loss of human life to the overall economic losses
varied from 6.5% to as high as 50% [6].
Over time, the range of health impacts included has
expanded and the current and future deaths and cases
have been estimated based on more precise underlying
data on both climate impact and the link to health out-
comes. Bosello estimates mortality and years lived with
disease due to climate change for six diseases [10].
Using a general equilibrium model the study found that
the economy-wide impacts of health impacts are greater
than simple aggregation of the health costs of different
diseases. In the EU, another study found that climate
change would produce net annual economic benefits of
€ 25 billion in the 2020s due to reduced cold deaths
exceeding increased heat-related deaths [11]. These net
benefits of climate change gradually reduce over time
until the 2080s when, for some scenarios, net health
impacts turn negative. The damage costs of increased
Salmonella cases in the EU due to higher average tem-
peratures has also been estimated, with an annual
damage cost of between € 70-139 million until 2040,
based on the average medical treatment cost per case of
€3,500 [12].
There are several problems with these damage cost
studies. One problem is the exclusion of potentially
important impacts. For example, most studies value only
increased deaths and omit the value of lost productivity
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dies include only a small range of diseases, usually tem-
perature-related and malaria, and omit other climate-
sensitive health impacts, such as extreme weather
events, waterborne diseases, air pollution and airborne
diseases, and other vector-borne diseases such as tick-
borne encephalitis or dengue fever.
A second problem is the inherent problem of valuing
life. Values are often widely diverging between different
studies. Also, global studies value loss of human life
based on the GDP of each country, hence giving higher
values to richer countries [13]. The unwanted policy
consequence of this approach is that adaptation
resources would appear to have greater return in richer
than in poorer countries.
A third problem is the valuation of impacts far into
the future. At larger discount rates, future welfare
impacts quickly reduce to a small proportion of their
impacts at present values. On the one hand, it is argued
that low or zero discount rates for long-term projects
accord with the way people think (reflecting the time
preference method of setting discount rates) [14]. On
the other hand, a low or zero discount rate leads to dis-
torted capital markets, given that most investments are
based on the short-term opportunity cost of capital [15].
There is still no consensus on the most appropriate dis-
count rate for measuring climate change impacts.
A second type of damage cost study emerging in the
climate change field assesses the damage costs averted
of (localised) health co-benefits of mitigation measures.
To date, such studies are very few [16,17]. For example,
the impact assessment accompanying the European
Commission Climate and Energy Package indicated that
by reducing greenhouse gas (GHG) emissions by 20% in
2020, sulphur dioxide, nitrogen oxides and PM2.5 emis-
sions would be reduced by 10-15% compared to baseline
emissions in 1990, thus reducing health damage costs by
between € 12-29 billion [18]. In the EU, China and
India, health gains are valued at US$ 145 billion in 2030
from low carbon electricity generation, compared to a
business-as-usual scenario [19]. The key message for
policy makers of these studies is that carbon reduction
measures should not be viewed as only costing money,
because they also bring immediate and valuable health
benefits. The implication is that taking into account
health gains can influence the type of carbon reduction
measures selected.
Health adaptation costs
More recently, attention has been turning from damage
cost studies to adaptation cost studies, for which there
exist global, regional as well as national studies [20,21].
While there are very few examples so far of health adap-
tation cost studies, there are ongoing efforts by coun-
tries to estimate costs of implementing adaptation
strategies in the context of National Adaptation Pro-
grammes of Action (NAPA) whose main goal is to iden-
tify priorities for adaptation to climate change in diverse
sectors. Health adaptation planning methodology has
been supported by guidance from the World Health
Organization [22], and more recently updated vulner-
ability, impact and adaptation (V&A) assessment guide-
lines [23].
Two global health adaptation cost assessments have
been conducted as part of multi-sectoral assessments,
namely the World Bank study “Economics of Adapta-
tion to Climate Change” in 2010 [24] and the
UNFCCC report “Investment and Financial Flows to
Address Climate Change” in 2007 [25]. A third global
study focuses on health adaptation costs only [26]. All
of these studies include diarrheal diseases, malaria and
malnutrition. Only the World Bank study explicitly
takes into account future economic development, and
therefore increased health resilience to climate
impacts. The adaptation costs are estimated as the
number of additional cases attributed to climate
change multiplied by the unit cost of health interven-
tions, consisting of a mixture of preventive and treat-
ment interventions. The results of these studies are
compared in Table 2. For the multi-sectoral studies,
the sectors in which actions have direct health benefits
such as water supply, agriculture, fisheries and extreme
weather, are also presented. Table 2 shows the propor-
tion of adaptation costs directly relevant to health pro-
tection vary from 14% to 47%, depending on whether
high or low cost estimates are used. In the World
Bank study, the share of GDP of overall adaptation
costs declines from 0.22% in the decade 2010-19 to
0.12% in the decade 2040-49, due to the increased resi-
lience to climate change provided by economic growth.
Table 1 Classification of damage costs
1
Impact type More Direct More Indirect
More Tangible ￿ Health service use
￿ Related health seeking costs (e.g. transport and time)
￿ Impact on household income or productive time of individuals
￿ Impact on the wider economy through affected labour
More Intangible ￿ Morbidity (health-related quality of life)
￿ Loss of life
￿ Stress, trauma
￿ Uncertainty
1 Note the classification proposed gives a general indication of which damage costs tend to be ‘more’ or ‘less’ tangible and direct, but these can vary between
persons and contexts.
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nitude in the three studies. This is partly explained by
the fact that they are based on the same underlying
health impact data [27]. However, a high level of agree-
ment should not lead to a mistaken conclusion of accu-
racy of these estimates, and the three studies suffer the
same weaknesses [28]:
￿ Underlying weaknesses in the health estimates [27].
First, the health impact numbers are highly uncer-
tain due to major uncertainties in various input vari-
ables, including: the future emissions scenarios; the
future impact of climate change on temperature; the
link of temperature to other health-affecting climate
variables (e.g. rainfall, storms); and the implications
for health. Also, underlying health data, such as cur-
rent health burdens, are also highly uncertain, espe-
cially in developing countries where routine health
information systems are generally weak. Second, the
studies did not consider the full range of climate-
sensitive disease burdens. Heat-related impacts, dis-
aster-related (weather) impacts, and infectious dis-
eases other than malaria and diarrhoea have been
omitted. The costs of responding to future food
insecurity and malnutrition were only partially
considered.
￿ The unit costs of controlling the health impacts
are imprecise, drawing on generalized regional esti-
mates, and limited country-level cost data. Unjusti-
fied assumptions are made about the intervention
set (preventive and curative services chosen) imple-
mented to reduce the disease burden. The studies
include the most quantifiable adaptation costs only,
such as service delivery, and largely exclude the cost
of implementing new policies and of increasing
capacity to meet demand. Only costs that are
expected to be financed by public agencies, and not
private, were included in the World Bank study.
￿ The adaptation measures assume perfect foresight
and do not take into account the additional costs
when hedging a range of outcomes (under different
climate scenarios) or of mal-adaptation - where the
responses to climate change lead to worse health
outcomes due to faulty climate predictions.
￿ The time horizon of the adaptation cost studies
extend to a maximum 40 years into the future. How-
ever, health impacts are expected to be considerably
greater until, or even after, stabilisation occurs some
time in the 22
nd or 23
rd centuries. Furthermore,
under more extreme climate change scenarios invol-
v i n gf o re x a m p l eh i g h e rs e al e v e lr i s eo rw i d e s p r e a d
desertification, currently planned adaptation will
need to be revised to prevent more severe predicted
health impacts.
￿ Uncertainty about the development baseline.
Future adaptive capacity, including the adaptation
effects of predicted future economic growth (espe-
cially in developing countries) is highly uncertain
and thus difficult to take into account in the esti-
mates. The World Bank explicitly avoids counting
the (costs of the) health impacts that would be
averted due to ongoing economic development,
which increases the resilience of populations to cli-
mate change. However, other studies do not expli-
citly mention their assumptions on the development
baseline.
To date, only few examples exist of cost estimates of
health sector adaptation plans in the National Adapta-
tion Programme of Action [20]. One study from Bangla-
desh estimates an average annual adaptation cost in the
health sector, from 2010 to 2050, at US$ 18 million per
Table 2 Global annual cost of climate change adaptation










Period or time point 2010-2050 2030 2030
Health sector 2.0 3.8 - 4.4 3.3 - 10.7




Extreme weather 6.7 - -
Total health-related 30.0 26.8 - 29.4 3.8 - 4.4
Total (all) 89.6
4 56.8 - 193.4
5 -
% health-related 33.4% 13.8 - 47.1% -
’-’ not estimated
1 The World Bank study estimates the adaptation costs of two scenarios over
four decadal periods from 2010 until 2050. The scenario presented in the
table is from the National Centre for Atmospheric Research (NCAR) which is
labelled the ‘Wettest scenario’. For the other scenario from the
Commonwealth Scientific and Industrial Research Organization (CSIRO),
labelled the ‘Driest scenario’, the costs are as follows: human health (US$ 1.6
billion), water supply and flood protection (US$ 19.2 billion), agriculture
forestry and fisheries (US$ 7.3 billion), extreme weather events (US$ 6.5
billion).
2 Two scenarios were modelled for the health sector analysis: stabilisation of
CO2-equivalent greenhouse gases at 750 parts per million by volume (ppmv)
by 2210 and 550 ppmv by 2170. The table presents results for 550 ppmv. For
the 750 ppmv scenario, the costs vary US$ 4.5 to US$ 5.4 billion. The variation
is accounted for mainly by uncertainties in the number of additional malaria
cases. In the water sector, the two figures represent SRES B1 (lower cost) and
SRES A1 scenarios.
3 Scenarios similar to the UNFCCC study, as the latter used disease figures
from Ebi (2008). For the health impacts, Ebi drew on the WHO Global Burden
of Disease Study. The table presents results for 550 ppmv. For the 750 ppmv
scenario, the costs vary US$ 4.0 to US$ 12.6 billion. Under an unmitigated
emissions scenario, costs vary from US$ 5.9 to US$ 18.0 billion.
4 Other sectors are infrastructure and coastal zones. Under the driest scenario
these account for US$ 43.1 billion, taking the total global costs to US$ 77.7
billion.
5 Other sectors are infrastructure, coastal zones and natural ecosystems. On
infrastructure adaptation costs, there is a wide variation in cost between the
estimates based on the Munich Re data (US$ 8 billion) and the Association of
British Insurance data (US$ 130 billion).
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equal to 20% of per capita health spending, for popula-
tions affected by five climate-induced diseases (diar-
rhoea, skin diseases, malaria, mental disorders and
dengue). Under the National Economic, Environment
and Development Study for Climate Change (NEEDS)
project, whose aim is to estimate financing needs to
implement mitigation and adaptation measures, Ghana
estimates additional resources of US$ 350 million by
2020 to adapt to climate change in the health sector,
plus US$ 7.6 million per year for malaria control [30].
In this publication, no detail was provided on the meth-
odology, data sources and original published materials
for these estimates.
Health economic evaluation
A rational decision maker will ask what return or pay-
back they are getting on expenditure and resources they
control. There are several types of decision makers, such
as government ministries, district offices, health provi-
ders, commercial enterprises and households. Each one
will have a different perspective on the impacts of cli-
mate change, and the costs and benefits of adapting to
climate change. Indeed, economic evaluation should be
designed to be usable by a range of decision makers,
and hence reflect the viewpoints of the various stake-
holders. To date, no published economic evaluation stu-
dies have specifically examined the costs and benefits of
health adaptation in relation to averting the marginal
health risks of climate change [21,31]. An unpublished
study from Bangladesh estimates the economic effi-
ciency of a package of health adaptation options target-
ing diarrheal disease, skin problems, mental disorders,
malaria and dengue. The study monetizes the saved pri-
vate health expenditure and productive time of averted
illness. The benefit-cost ratio of intervention measures
is estimated to be 4.1, with an annual rate of return of
41% [29].
Other economic studies also indicate economic effi-
ciency, while they fall short of indicating the efficiency
of climate change-specific health risks. In one study,
the value of health benefits were compared to the
costs of heat-health early warning systems in Philadel-
phia [32]. The study estimated incremental financial
costs of the system of US$ 210,000, and the model
predicted 117 lives were saved over a 3 year period,
with a cost of US$ 1,795 per year of life saved. At a
value per saved life of US$ 4 million, the societal value
of saved lives was estimated at US$ 468 million. How-
ever, no climate-specific attribution factor was made.
Another study identified the climate change impact on
water supply in South Africa; however, health benefits
of adaptation options were not included in the cost-
benefit analysis [33].
H e n c et h e r ea r ev e r yl i m i t e ds t u d i e sa v a i l a b l et o
enable decision makers to understand how to most effi-
ciently address the rising burden from climate-sensitive
diseases. Current studies provide very imprecise infor-
mation on costs and benefits. This field is clearly in its
infancy. However, economic evaluation studies face a
major constraint in evaluating the cost-benefit or cost-
effectiveness of interventions to reduce the specific
health risks of climate change, due to the imprecision in
isolating these additional health risks from already pre-
sent health risks. Therefore decision makers should
draw on existing economic studies on environmental
health interventions that are not specific to climate
change. Such studies already exist in the fields of water
and sanitation, environmental vector control and air
pollution [34], as well as a larger number of economic
studies on curative services. On the one hand, the addi-
tional climate risk may increase the intervention (adap-
tation) costs, while on the other hand climate change
will lead to increases in potential health benefits of
these interventions - hence, the overall efficiency of
interventions may not change significantly under climate
change.
Conclusions and recommendations
This paper reviewed the economic evidence base to sup-
port adaptation decisions to protect health from climate
change, revealing large gaps in economic evidence. The
analysis suggests that the existing evidence base is gen-
erally of low quality, and given the current global nature
of many studies, is of limited relevance for decision
makers at national level and below. Until mid-2010,
only 23% of the UNFCCC-led National Adaptation Pro-
grammes of Action were considered to be comprehen-
sive in their health-vulnerability assessment and 27% (8/
30) of these health adaptation interventions were con-
sidered to be adequate [35]. 3% of budgeted funds were
destined for health. An even larger gap exists in assess-
ments of the value of health benefits in a cost-benefit or
cost-effectiveness framework, which ideally would be
used for making more efficient decisions on adaptation
policies and resource allocations [21].
Although evidence is incomplete, all published evi-
dence suggests significant health damage and adaptation
costs, which are an important proportion of overall
damage costs for climate change. If this is true, it fol-
lows that health should be an important component of
adaptation support. Furthermore, the short- to medium-
term impacts of climate change on health are mainly
expected to be exacerbations of existing effects. In this
case, we would expect the existing evidence base on
effectiveness of interventions to (roughly) apply, and can
conclude that much of the expected increased burden
could be avoided through scaling up existing cost-
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assesses the efficiency of intervention specifically in the
context of a changing environment, it should be consid-
ered acceptable for decision makers to draw on existing
economic evidence that is non-climate specific. One
area of focus should be on the implementation of poli-
cies which have a beneficial health impact even with
inaccurate predictions of the health impacts of climate
change (often termed ‘no regrets’ policies), which in the
short-term can potentially avert significant health
impacts, part of which are attributed to climate change.
Three major developments specific to the economics
evidence base could inform policy making. First, more
climate change-specific health economic guidelines and
tools. Second, further review of the existing environ-
mental health economic evidence base to assess rele-
vance for climate change-specific interventions. Third,
measures for improved dissemination and communica-
tion of economic results within the health sector as well
as mainstreamed into all relevant sectors. These three
proposed future developments in the economics evi-
dence base are elaborated below.
Improved guidelines and tools: Many of the uncer-
tainties identified in this study can be addressed
through more focused health studies at a higher level
of resolution at the national level. These studies would
also have the advantage of being able to directly
inform national and sub-national governments, form-
ing part of the national adaptation strategies and asso-
ciated fund raising activities. To be robust and
standardized, guidelines and tools are needed which
should describe the detailed research methodology,
outlining clearly the analytical choices, and providing
concrete guidance on which methods and values to use
in valuing benefits under climate change [36,37]. They
should specifically target government departments
wishing to make a cost or economic assessment of
health adaptation plans. Software-based tools aid the
researcher to enter the inputs and generate the outputs
in a standardized way. When conducting economic
evaluation, analysts should conduct cost-effectiveness
and cost-benefit analysis together, to be of wider
appeal not only to health ministries (who tend to use
CEA) but also other ministries (who are more inter-
ested in CBA, especially if it includes benefits relevant
to their mission). To increase social efficiency, a wide
range of interventions should be evaluated, even if they
are under the responsibility of different government
departments. For example, to reduce diarrheal disease
burden, the economic performance of curative care
should be compared with preventive interventions
implemented by the health sector such as rotavirus or
cholera vaccinations, as well as with preventive inter-
ventions under the charge of other ministries such as
water resource protection. Multidisciplinary research
on climate-health links, adaptation and mitigation
measures should include health economic analysis [38].
Given the substantial health gains that can be made
through actions in other sectors, it is crucial to adopt
a broader multi-sectoral perspective in the cost analy-
sis. Furthermore, health economic guidelines should
link climate change adaptation and mitigation from a
health policy perspective.
Review of existing economic evidence base on climate
change-sensitive health burdens: to date, environmental
health economic studies do not specifically incorporate
climate change considerations. Therefore, a review of
studies should be carried out that provides a climate
change angle - for example, assessing how costs and
benefits would be altered under climate change. Based
on determinants of costs and efficiency - such as under-
lying disease risk, climate change and variability, relative
prices of goods and services, and existing policies and
interventions - it needs to be described clearly how evi-
dence from one context can be transferred or extrapo-
lated to other contexts.
Improved dissemination and communication of eco-
nomic results: to encourage greater use of (economic)
evidence in decision making, economic data should be
presented in a manner that is easily understood by pol-
icy makers. Aside from providing short and digestible
summaries of research results to decision makers [39],
other improvements are needed in the presentation and
use of economic evidence. For example, multi-criteria
analysis - which is used either explicitly or implicitly in
most decisions - can be expanded to include more eco-
nomic variables. Opportunities for health gains should
be made more explicit to decision makers, with support-
ing evidence, such as ‘no regrets’ policies or interven-
tions that have ancillary (co-)benefits. Decision makers
in other sectors such as energy, transport, housing,
infrastructure, drinking water, agriculture and emer-
gency services also need to be shown how their inter-
ventions can be fine-tuned to have greater positive
impact on health. Furthermore, using the evidence base
more effectively in health policy related to climate
change may have positive spill-over effects on the entire
health sector, hence bringing greater benefits than just
averting the disease burden attributed to climate change.
Future economic studies on climate change and health
should not be implemented in isolation from other
initiatives. Most importantly, this includes having a
strong link with national adaptation activities to pro-
mote rational decision making using an improved health
economic evidence base. These activities include NAPAs
and other capacity-building projects such as UNFCCC’s
NEEDS project; UNDP’s “Capacity Development for Pol-
icy Makers to Address Climate Change” whose aim is to
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ments in long-term investment and financial flows; and
a global project implemented at regional level “Review
of the Economics of Climate Change” (RECC) whose
aim is to contribute to the regional debate on the costs
and benefits of climate change adaptation and mitiga-
tion, including advocacy and support to governments
and the private sector.
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